Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05244525 · ClinicalTrials.gov registry record · Phase 4
Subacromial Injection of Epinephrine Improves Visualization in Shoulder Arthroscopy
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT05244525 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 60 participants.
The verdict
NCT05244525, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate surgeon-rated visual clarity and the need for increased irrigation pump pressure during arthroscopic shoulder surgery and to evaluate mean arterial pressure, operative time, and any adverse events that occur during arthroscopic shoulder surgery.
Interventions
- DRUG Bupivacaine with Epinephrine
- DRUG Bupivacaine alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-03-14 |
| Est. Completion | 2022-08-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05244525
The ClinicalTrials.gov registry entry for NCT05244525 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine with Epinephrine is the first listed.
NCT05244525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05244525 about?
NCT05244525 is a clinical study titled "Subacromial Injection of Epinephrine Improves Visualization in Shoulder Arthroscopy". The purpose of this study is to evaluate surgeon-rated visual clarity and the need for increased irrigation pump pressure during arthroscopic shoulder surgery and to evaluate mean arterial pressure, operative time, and any adverse events that occur during arthroscopic shoulder surgery.
What is the current status of trial NCT05244525?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2022-03-14. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT05244525?
The interventions under investigation include: Bupivacaine with Epinephrine (DRUG), Bupivacaine alone (DRUG).
Who is sponsoring clinical trial NCT05244525?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.